Skip to main content
Top
Published in: Endocrine 2/2021

01-11-2021 | Pituitary Adenoma | Correction

Correction to: Tumor volume improves preoperative differentiation of prolactinomas and nonfunctioning pituitary adenomas

Authors: Kyla Wright, Matthew Lee, Natalie Escobar, Donato Pacione, Matthew Young, Girish Fatterpekar, Nidhi Agrawal

Published in: Endocrine | Issue 2/2021

Login to get access

Excerpt

Correction to: Endocrine
Metadata
Title
Correction to: Tumor volume improves preoperative differentiation of prolactinomas and nonfunctioning pituitary adenomas
Authors
Kyla Wright
Matthew Lee
Natalie Escobar
Donato Pacione
Matthew Young
Girish Fatterpekar
Nidhi Agrawal
Publication date
01-11-2021
Publisher
Springer US
Published in
Endocrine / Issue 2/2021
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-021-02777-z

Other articles of this Issue 2/2021

Endocrine 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine